Literature DB >> 20353885

Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system.

Ying Xu1, Zhichao Wang, Wenting You, Xiuhua Zhang, Shan Li, Philip A Barish, Matthew M Vernon, Xia Du, Gaowen Li, Jianchun Pan, William O Ogle.   

Abstract

The antidepressant-like effect of trans-resveratrol, a phenolic compound present in polygonum cuspidatum, was evaluated through behavioral and neurochemical methods. trans-Resveratrol (20, 40 and 80 mg/kg, via gavage) significantly decreased the immobility time in mouse models of despair tests, but did not influence locomotor activity. Two behavioral models and neurochemical assays suggested that trans-resveratrol produced a significant increase in serotonin and noradrenaline levels at 40 or 80 mg/kg in brain regions. In addition, trans-resveratrol dose dependently inhibited MAO-A activity. These findings indicate that the antidepressant-like effect of trans-resveratrol might be related to serotonergic and noradrenergic activation. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20353885     DOI: 10.1016/j.euroneuro.2010.02.013

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  56 in total

Review 1.  New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors.

Authors:  Michael Maes; Zdenĕk Fišar; Miguel Medina; Giovanni Scapagnini; Gabriel Nowak; Michael Berk
Journal:  Inflammopharmacology       Date:  2012-01-24       Impact factor: 4.473

Review 2.  Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system.

Authors:  Jaewon Lee; Dong-Gyu Jo; Daeui Park; Hae Young Chung; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

Review 3.  Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function.

Authors:  David O Kennedy; Emma L Wightman
Journal:  Adv Nutr       Date:  2011-01-10       Impact factor: 8.701

4.  Neurobehavioural evaluation of resveratrol in murine models of anxiety and schizophrenia.

Authors:  Mohammed Garba Magaji; Loretta Oghenekome Iniaghe; Mutiat Abolarin; Opeyemi Isa Abdullahi; Rabiu Abdusalam Magaji
Journal:  Metab Brain Dis       Date:  2016-11-22       Impact factor: 3.584

5.  Morus nigra and its major phenolic, syringic acid, have antidepressant-like and neuroprotective effects in mice.

Authors:  Ana Paula Dalmagro; Anderson Camargo; Ana Lúcia Bertarello Zeni
Journal:  Metab Brain Dis       Date:  2017-08-18       Impact factor: 3.584

6.  Improving effect of chronic resveratrol treatment on central monoamine synthesis and cognition in aged rats.

Authors:  F Sarubbo; M R Ramis; S Aparicio; L Ruiz; S Esteban; A Miralles; D Moranta
Journal:  Age (Dordr)       Date:  2015-04-22

Review 7.  Molecular Mechanisms Underlying the Anti-depressant Effects of Resveratrol: a Review.

Authors:  Marcos Roberto de Oliveira; Aline Lukasievicz Chenet; Adriane Ribeiro Duarte; Giselli Scaini; João Quevedo
Journal:  Mol Neurobiol       Date:  2017-07-10       Impact factor: 5.590

8.  Antidepressant-like effects of ferulic acid: involvement of serotonergic and norepinergic systems.

Authors:  Jianliang Chen; Dan Lin; Chong Zhang; Gaowen Li; Nianping Zhang; Lina Ruan; Qizhi Yan; Jianxin Li; Xuefeng Yu; Xupei Xie; Cong Pang; Liang Cao; Jianchun Pan; Ying Xu
Journal:  Metab Brain Dis       Date:  2014-12-09       Impact factor: 3.584

9.  Association of habitual dietary resveratrol exposure with the development of frailty in older age: the Invecchiare in Chianti study.

Authors:  Montserrat Rabassa; Raul Zamora-Ros; Mireia Urpi-Sarda; Stefania Bandinelli; Luigi Ferrucci; Cristina Andres-Lacueva; Antonio Cherubini
Journal:  Am J Clin Nutr       Date:  2015-10-21       Impact factor: 7.045

Review 10.  Resveratrol and Alzheimer's Disease: Mechanistic Insights.

Authors:  Touqeer Ahmed; Sehrish Javed; Sana Javed; Ameema Tariq; Dunja Šamec; Silvia Tejada; Seyed Fazel Nabavi; Nady Braidy; Seyed Mohammad Nabavi
Journal:  Mol Neurobiol       Date:  2016-03-19       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.